These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 28594717)

  • 1. Long-term Risk of Urinary Adverse Events in Curatively Treated Patients With Rectal Cancer: A Population-Based Analysis.
    Kwaan MR; Fan Y; Jarosek S; Elliott SP
    Dis Colon Rectum; 2017 Jul; 60(7):682-690. PubMed ID: 28594717
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Propensity-Weighted Comparison of Long-Term Risk of Urinary Adverse Events in Elderly Women Treated For Cervical Cancer.
    Elliott SP; Fan Y; Jarosek S; Chu H; Downs L; Dusenbery K; Geller MA; Virnig BA
    Int J Radiat Oncol Biol Phys; 2015 Jul; 92(3):586-93. PubMed ID: 25890845
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Surveillance, epidemiology, and end results-based analysis of the impact of preoperative or postoperative radiotherapy on survival outcomes for T3N0 rectal cancer.
    Peng LC; Milsom J; Garrett K; Nandakumar G; Coplowitz S; Parashar B; Nori D; Clifford Chao KS; Wernicke AG
    Cancer Epidemiol; 2014 Feb; 38(1):73-8. PubMed ID: 24491755
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Radiation therapy improves survival in rectal small cell cancer - Analysis of Surveillance Epidemiology and End Results (SEER) data.
    Modrek AS; Hsu HC; Leichman CG; Du KL
    Radiat Oncol; 2015 Apr; 10():101. PubMed ID: 25902707
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Impact of Preoperative Radiation Therapy on Locoregional Recurrence in Patients with Stage IV Rectal Cancer Treated with Definitive Surgical Resection and Contemporary Chemotherapy.
    Manyam BV; Mallick IH; Abdel-Wahab MM; Reddy CA; Remzi FH; Kalady MF; Lavery I; Koyfman SA
    J Gastrointest Surg; 2015 Sep; 19(9):1676-83. PubMed ID: 26014718
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Oxaliplatin added to fluorouracil-based preoperative chemoradiotherapy and postoperative chemotherapy of locally advanced rectal cancer (the German CAO/ARO/AIO-04 study): final results of the multicentre, open-label, randomised, phase 3 trial.
    Rödel C; Graeven U; Fietkau R; Hohenberger W; Hothorn T; Arnold D; Hofheinz RD; Ghadimi M; Wolff HA; Lang-Welzenbach M; Raab HR; Wittekind C; Ströbel P; Staib L; Wilhelm M; Grabenbauer GG; Hoffmanns H; Lindemann F; Schlenska-Lange A; Folprecht G; Sauer R; Liersch T;
    Lancet Oncol; 2015 Aug; 16(8):979-89. PubMed ID: 26189067
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Laparoscopic vs open abdominoperineal resection in the multimodality management of low rectal cancers.
    Wang YW; Huang LY; Song CL; Zhuo CH; Shi DB; Cai GX; Xu Y; Cai SJ; Li XX
    World J Gastroenterol; 2015 Sep; 21(35):10174-83. PubMed ID: 26401082
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intermediate Neoadjuvant Radiotherapy Combined With Total Mesorectal Excision for Locally Advanced Rectal Cancer: Outcomes After a Median Follow-Up of 5 Years.
    Wang L; Li YH; Cai Y; Zhan TC; Gu J
    Clin Colorectal Cancer; 2016 Jun; 15(2):152-7. PubMed ID: 26508595
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Survival outcome of operated and non-operated elderly patients with rectal cancer: A Surveillance, Epidemiology, and End Results analysis.
    Bhangu A; Kiran RP; Audisio R; Tekkis P
    Eur J Surg Oncol; 2014 Nov; 40(11):1510-6. PubMed ID: 24704032
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparative Survival of Patients With Anal Adenocarcinoma, Squamous Cell Carcinoma of the Anus, and Rectal Adenocarcinoma.
    Franklin RA; Giri S; Valasareddy P; Lands LT; Martin MG
    Clin Colorectal Cancer; 2016 Mar; 15(1):47-53. PubMed ID: 26362848
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Secondary malignancies after rectal cancer resection with and without radiation therapy: A propensity-adjusted, population-based SEER analysis.
    Warschkow R; Güller U; Cerny T; Schmied BM; Plasswilm L; Putora PM
    Radiother Oncol; 2017 Apr; 123(1):139-146. PubMed ID: 28285840
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Outcomes of multimodality therapies for patients with stage II or III rectal cancer in California, 1994-2009.
    Cho MM; Morgan JW; Knutsen R; Oda K; Shavlik D; Knutsen S; Kazanjian K
    Dis Colon Rectum; 2013 Dec; 56(12):1357-65. PubMed ID: 24201389
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Implications for determining the optimal treatment for locally advanced rectal cancer in elderly patients aged 75 years and older.
    Wan JF; Zhu J; Li GC; Sun WJ; Zhang Z
    Oncotarget; 2015 Oct; 6(30):30377-83. PubMed ID: 26160846
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long-term prognostic value of mesorectal grading after neoadjuvant chemoradiotherapy for rectal cancer.
    Madbouly KM; Hussein AM; Abdelzaher E
    Am J Surg; 2014 Sep; 208(3):332-41. PubMed ID: 24581995
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bowel Dysfunction After Low Anterior Resection With Neoadjuvant Chemoradiotherapy or Chemotherapy Alone for Rectal Cancer: A Cross-Sectional Study from China.
    Qin Q; Huang B; Cao W; Zhou J; Ma T; Zhou Z; Wang J; Wang L
    Dis Colon Rectum; 2017 Jul; 60(7):697-705. PubMed ID: 28594719
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Population-based assessment of the surgical management of locally advanced colorectal cancer.
    Govindarajan A; Coburn NG; Kiss A; Rabeneck L; Smith AJ; Law CH
    J Natl Cancer Inst; 2006 Oct; 98(20):1474-81. PubMed ID: 17047196
    [TBL] [Abstract][Full Text] [Related]  

  • 17. New Rates of Interventions to Manage Complications of Modern Prostate Cancer Treatment in Older Men.
    Wallis CJ; Mahar A; Cheung P; Herschorn S; Klotz LH; Al-Matar A; Kulkarni GS; Lee Y; Kodama RT; Narod SA; Nam RK
    Eur Urol; 2016 May; 69(5):933-41. PubMed ID: 26572707
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Multicenter study of outcome in relation to the type of resection in rectal cancer.
    Ortiz H; Wibe A; Ciga MA; Kreisler E; Garcia-Granero E; Roig JV; Biondo S;
    Dis Colon Rectum; 2014 Jul; 57(7):811-22. PubMed ID: 24901681
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Predicting the Risk of Bowel-Related Quality-of-Life Impairment After Restorative Resection for Rectal Cancer: A Multicenter Cross-Sectional Study.
    Battersby NJ; Juul T; Christensen P; Janjua AZ; Branagan G; Emmertsen KJ; Norton C; Hughes R; Laurberg S; Moran BJ;
    Dis Colon Rectum; 2016 Apr; 59(4):270-80. PubMed ID: 26953985
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efforts to improve local control in rectal cancer compromise survival by the potential morbidity of optimal mesorectal excision.
    Laurent C; Nobili S; Rullier A; Vendrely V; Saric J; Rullier E
    J Am Coll Surg; 2006 Nov; 203(5):684-91. PubMed ID: 17084330
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.